ストックスクリーナーアプリを入手
5.33
3.70%
0.19
プレマーケット:
5.33
前日終値:
$5.14
開ける：
$5.17
24時間の取引高:
253.96K
Relative Volume:
0.36
時価総額：
$191.07M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+14.87%
1か月 パフォーマンス:
-13.19%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$4.83
$5.38
1週間の範囲:
$4.40
$5.38
52週間の値動き範囲:
$3.85
$26.62
Bioage Labs Inc Stock (BIOA) Company Profile
BIOA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BIOA
Bioage Labs Inc
|
5.33 | 191.07M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
167.53 | 75.58B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.24 | 41.78B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.10 | 41.53B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
21.82 | 24.72B | 16.77B | -959.00M | 1.37B | -0.85 |
|
NBIX
Neurocrine Biosciences Inc
|
145.88 | 14.77B | 2.24B | 385.90M | 440.10M | 3.73 |
Bioage Labs Inc Stock (BIOA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-10 | ダウングレード | Morgan Stanley | Overweight → Underweight |
| 2024-12-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2024-12-09 | ダウングレード | Jefferies | Buy → Hold |
| 2024-10-21 | 開始されました | Citigroup | Buy |
| 2024-10-21 | 開始されました | Jefferies | Buy |
| 2024-10-21 | 開始されました | Morgan Stanley | Overweight |
すべてを表示
Bioage Labs Inc (BIOA) 最新ニュース
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Lawsuit - PR Newswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in BioAge Labs, Inc. of Class Action Lawsuit and Upcoming DeadlinesBIOA - PR Newswire
BioAge Labs, Inc. Sued for Securities Law Violations - GlobeNewswire
BIOA Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges BIOA Investors with Losses to Contact the Firm - GlobeNewswire
BIOA DEADLINE NOTICE: BioAge Labs Investors are Reminded of March 10 Class Action Deadline – Contact BFA Law if You Lost Money (NASDAQ:BIOA) - GlobeNewswire Inc.
Investors in BioAge Labs, Inc. Should Contact Levi & Korsinsky B - GuruFocus.com
BioAge Labs (BIOA) Faces Securities Class Action On Behalf - GlobeNewswire
2025-01-20 | BIOA DEADLINE: The March 10 BioAge Labs Class Action Deadline is ApproachingContact BFA Law if You Suffered Losses | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Longview News-Journal
The Gross Law Firm Reminds BioAge Investors of the Pending Class - GuruFocus.com
The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - PR Newswire
BIOA LEGAL NEWS: A Class Action has been Filed Against - GlobeNewswire
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - PR Newswire
ROSEN, A RESPECTED AND LEADING FIRM, Encourages BioAge Labs, Inc. Investors to Secure Counsel - The Bakersfield Californian
DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of BioAge Labs - Markets Insider
BIOA INVESTOR ALERT: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds - GlobeNewswire
2025-01-17 | BIOA LEGAL ALERT: BioAge Labs Sued after Stock Drops 76%Investors with Losses are Urged to Contact BFA Law before March 10 Class Action Deadline | NDAQ:BIOA | Press Release - Stockhouse Publishing
Deadline Alert: BioAge Labs, Inc. (BIOA) Investors Who Lost - GlobeNewswire
Faruqi & Faruqi Reminds BioAge Investors of the Pending - GlobeNewswire
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge - GuruFocus.com
BioAge Labs, Inc. Class Action: Levi & Korsinsky Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025BIOA - Morningstar
Kirby McInerney LLP Reminds BioAge Labs, Inc. (BIOA) - GlobeNewswire
Levi & Korsinsky Reminds BioAge Investors of the Pending - GlobeNewswire
DEADLINE ALERT for RVNC, REGN, and BIOA: The Law Offices of - GlobeNewswire
BIOA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire
Investors who lost money on BioAge Labs, Inc.(BIOA) should - GlobeNewswire
2025-01-15 | BioAge Labs, Inc. Class Action Notice: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the BIOA Class Action | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA SHAREHOLDER ALERT: BFA Law Reminds BioAge Labs, Inc. - GlobeNewswire
Class Action Announcement for BioAge Labs, Inc. (BIOA): Kessler Topaz Meltzer & Check, LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against BioAge Labs, Inc. - PR Newswire
BIOA INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP - GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Investors That Class - GlobeNewswire
TSX Composite Index (TXCX) QuotePress Release - The Globe and Mail
2025-01-14 | BIOA SHAREHOLDER NEWS: BFA Law Announces that a Class Action has been filed against BioAge Labs, Inc.Contact the Firm if You Suffered Losses | NDAQ:BIOA | Press Release - Stockhouse Publishing
BIOA Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against BioAge Labs, Inc. - Business Wire
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should c - GuruFocus.com
Shareholders that lost money on BioAge Labs, Inc.(BIOA) should contact Levi & Korsinsky about pending Class ActionBIOA - Morningstar
BIOA Shareholder Alert: Shareholder Rights Law Firm Robbins - GlobeNewswire
BIOA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
BIOA LAWSUIT ALERT: Levi & Korsinsky Notifies BioAge Labs, - GlobeNewswire
Novartis & BioAge Team Up To Develop Aging Therapies And Boost Investor Potential (BIOA) - Seeking Alpha
Law Offices of Frank R. Cruz Encourages BioAge Labs, Inc. (BIOA) Investors to Inquire About Securities Fraud Class Action - Business Wire
BIOA CLASS ACTION NEWS: BioAge Labs, Inc. Investors are - GlobeNewswire
BioAge Labs, Inc. Securities Fraud Class Action Lawsuit Pending: - GuruFocus.com
BIOA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BIOA - AccessWire
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - The Malaysian Reserve
BIOA INVESTOR NOTICE: BioAge Labs, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – Company AnnouncementFT.com - Financial Times
BIOA CLASS ACTION ALERT: BioAge Labs Investors that Lost - GlobeNewswire
Bioage Labs Inc (BIOA) 財務データ
Bioage Labs Inc (BIOA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Bioage Labs Inc (BIOA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Pande Vijay Satyanand | Director |
Oct 02 '24 |
Buy |
19.73 |
67,096 |
1,323,804 |
1,093,889 |
| Pande Vijay Satyanand | Director |
Oct 03 '24 |
Buy |
19.90 |
25,306 |
503,589 |
1,119,195 |
| Cormorant Asset Management, LP | Former 10% Owner |
Sep 27 '24 |
Buy |
18.00 |
450,000 |
8,100,000 |
1,629,529 |
| Pande Vijay Satyanand | Director |
Sep 27 '24 |
Buy |
18.00 |
900,000 |
16,200,000 |
900,000 |
| ENRIGHT PATRICK G | Director |
Sep 27 '24 |
Buy |
18.00 |
400,000 |
7,200,000 |
1,710,589 |
| HEALY JAMES | Director |
Sep 27 '24 |
Buy |
18.00 |
666,665 |
11,999,970 |
2,227,124 |
2.14%
大文字化:
|
ボリューム (24 時間):